Jade Biosciences (JBIO) Shares Issued (2021 - 2026)

Jade Biosciences posted quarterly Shares Issued of $45000.0 for Q1 2026, up 111.36% on a QoQ basis from -$396000.0 in Q2 2024.

Jade Biosciences (JBIO) has 5 years of Shares Issued data on file, last reported at $45000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $45000.0; the trailing twelve-month figure through Mar 2026 stood at -$351000.0 (changed N/A YoY), and the FY2025 full-year result was $88000.0, down 71.43% from the prior year.
  • Shares Issued for Q1 2026 stood at $45000.0, up from -$396000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $758000.0 in Q4 2023 and bottomed at -$396000.0 in Q2 2024.
  • The 4-year median for Shares Issued is $172000.0 (2022), against an average of $165222.2.
  • Peak annual rise in Shares Issued reached 3258.33% in 2023, while the deepest fall reached 290.7% in 2023.
  • A 4-year view of Shares Issued shows it stood at -$24000.0 in 2022, then jumped by 3258.33% to $758000.0 in 2023, then plunged by 152.24% to -$396000.0 in 2024, then soared by 111.36% to $45000.0 in 2026.
  • The last three Shares Issued figures came in at $45000.0 (Q1 2026), -$396000.0 (Q2 2024), and $704000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 5.40 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 27.00 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 163.10 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 13.16 Mn
10 Jade Biosciences 1.06 Bn 1.06 Bn - 45,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 45,000.00
Mar 31, 2026 45,000.00
Jun 30, 2024 -396,000.00
Jun 30, 2024 -396,000.00
Mar 31, 2024 704,000.00
Mar 31, 2024 704,000.00
Dec 31, 2023 758,000.00
Dec 31, 2023 758,000.00
Sep 30, 2023 -328,000.00
Sep 30, 2023 -328,000.00
Jun 30, 2023 333,000.00
Jun 30, 2023 333,000.00
Mar 31, 2023 223,000.00
Mar 31, 2023 223,000.00
Dec 31, 2022 -24,000.00
Dec 31, 2022 -24,000.00
Sep 30, 2022 172,000.00
Sep 30, 2022 172,000.00
Dec 31, 2021 -250,000.00
Dec 31, 2021 -250,000.00